by Latona Giwa | Jun 25, 2026 | Abortion, Abortion Access, abortion ban, abortion bans, Dobbs v. Jackson, Dobbs v. Jackson Women’s Health Organization, health care, health care access, medical care, medical workers, Op-Ed, Reproductive Care, Reproductive Rights, Roe v. Wade
Reproductive health clinics have been closing at alarming rates since the Supreme Court ended federal abortion protections in 2022. Facing mounting social and economic pressures, at least 100 clinics closed between the fall of Roe v. Wade and June 2025, the latest data available. Every time a clinic closes, patients lose access to care, but that’s not all: Whole communities lose their…
Source
by Marianne Dhenin | Jun 23, 2026 | Abortion, Ballot Measures, Dobbs v. Jackson Women’s Health Organization, Idaho, Nevada, News, Virginia
It has been four years since the Supreme Court’s decision in Dobbs v. Jackson Women’s Health Organization eliminated the federal constitutional right to abortion, leaving people in the U.S. to navigate a confusing patchwork of abortion protections, restrictions, and outright bans depending on jurisdiction. Organizers have ramped up efforts to improve access since the ruling, and thanks to that…
Source
by Sofia Resnick | Jun 18, 2026 | Abortion, News, Pregnancy, Reproductive Rights, sexual health, Title X, Trump Administration
A federal poverty-fighting program focused on reducing unintended pregnancies is about to undergo a major overhaul. Reproductive health clinics use Title X federal grant money to provide birth control, cancer screenings and testing and treatment for sexually transmitted infections to people with little or no health insurance. Title X money cannot be used for abortions.
Source
by Chris Walker | Jun 8, 2026 | Abortion, abortion medication, Food and Drug Administration, mifepristone, News, Supreme Court
The U.S. Food and Drug Administration (FDA) has launched a study that purports to examine the safety of the widely used abortion medication mifepristone, a move that critics say could be used as a means to further regulate the drug and restrict abortion access. FDA administrators deny that the study, revealed in a Wall Street Journal report late last week, is new, asserting it has been going…
Source
by Emma Cieslik | May 19, 2026 | Abortion, Comstock Act, Dobbs v. Jackson, mifepristone, News Analysis, Roe v. Wade, Supreme Court
On May 1, the New Orleans-based 5th U.S. Circuit Court of Appeals blocked the mailing of mifepristone, a common abortion medication. The ruling restricted distribution and use of the medication to in-person clinic visits only, even as the number of brick-and-mortar abortion clinics has continued to shutter over the past year, and some red states blocked access to mail order pills.
Source
by Grace E. Howard | May 5, 2026 | Abortion, Abortion Pills, Alabama, Criminalization, Dobbs v. Jackson Women’s Health Organization, mifepristone, Op-Ed, Telehealth
In the aftermath of the Dobbs v. Jackson Women’s Health Organization Supreme Court decision that overturned Roe v. Wade, there has been increased movement toward criminalization of abortion. The Fifth Circuit Court recently ordered the Food and Drug Administration (FDA) to rescind guidance permitting the use of telemedicine for mifepristone, one of the two medications used for medication…
Source